Renin-angiotensin-aldosterone system (RAAS) inhibitor, Zestril, Purity ≥98%

Synonym: 83915-83-7; Lisinopril dihydrate; 83915-83-7; Renacor; Ranolip; Lisinopril (dihydrate); MK-521; (2S)-1-[(2S)-6-Amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid; dihydrate; Renin-angiotensin-aldosterone system (RAAS) inhibitor

MDL: MFCD01698825
CAS Number: 83915-83-7
Compound CID: 5362118

Product Size

500 mg; 1 g; 2 g; 5 g

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Zestril, insoluble in DMSO and ethanol and soluble in water, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of angiotensin-converting enzyme (ACE) by inhibiting endocrinology-hormones. The molecular weight of the compound is 441.52, and its molecular formula is C₂₁H₃₁O₅N₃·2(H₂O).

Molecular Weight

441.52

Molecular Formula

C₂₁H₃₁O₅N₃·2(H₂O)

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: insoluble; Water: 18 mg/mL (40.76 mM; Ethanol: insoluble

Identity

Confirmed by NMR/HPLC/MS.

Applications

Zestril displays the significant potential to act as an effective ACE inhibitor that prevents the conversion of angiotensin I to angiotensin II, leading to decreased blood pressure.